These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31097354)

  • 1. Apoptosis, necroptosis and autophagy in colorectal cancer: Associations with tumor aggressiveness and p53 status.
    Sakanashi F; Shintani M; Tsuneyoshi M; Ohsaki H; Kamoshida S
    Pathol Res Pract; 2019 Jul; 215(7):152425. PubMed ID: 31097354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-armed oncolytic adenovirus induces autophagy and apoptosis in KRAS and BRAF-mutant colorectal cancer cells.
    Tamura S; Tazawa H; Hori N; Li Y; Yamada M; Kikuchi S; Kuroda S; Urata Y; Kagawa S; Fujiwara T
    PLoS One; 2023; 18(11):e0294491. PubMed ID: 37972012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosis.
    Mitomi H; Ohkura Y; Fukui N; Kanazawa H; Kishimoto I; Nakamura T; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Saigenji K
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):883-9. PubMed ID: 17873613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among
    Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
    World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
    Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
    Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of FIH-1 and SOCS3 expression in KRAS mutant and wild-type patients with colorectal cancer.
    Vakil L; Najafipour R; Rakhshani N; Zamani F; Morakabati A; Javadi A
    Tumour Biol; 2016 Jul; 37(7):8841-8. PubMed ID: 26749281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated MLKL attenuates autophagy following its translocation to intracellular membranes.
    Frank D; Vaux DL; Murphy JM; Vince JE; Lindqvist LM
    J Cell Sci; 2019 Feb; 132(5):. PubMed ID: 30709919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status.
    Schmitz KJ; Ademi C; Bertram S; Schmid KW; Baba HA
    World J Surg Oncol; 2016 Jul; 14(1):189. PubMed ID: 27444698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases.
    Miranda E; Bianchi P; Destro A; Morenghi E; Malesci A; Santoro A; Laghi L; Roncalli M
    Cancer; 2013 Jan; 119(2):266-76. PubMed ID: 22786759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior.
    Jang S; Hong M; Shin MK; Kim BC; Shin HS; Yu E; Hong SM; Kim J; Chun SM; Kim TI; Choi KC; Ko YW; Kim JW
    Hum Pathol; 2017 Jul; 65():21-30. PubMed ID: 28188750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model.
    Alamo P; Gallardo A; Di Nicolantonio F; Pavón MA; Casanova I; Trias M; Mangues MA; Lopez-Pousa A; Villaverde A; Vázquez E; Bardelli A; Céspedes MV; Mangues R
    FASEB J; 2015 Feb; 29(2):464-76. PubMed ID: 25359494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual role of sprouty2 as an inhibitor of RAS/ERK-driven proliferation and a promoter of cancer invasion in KRAS wild-type colorectal cancer.
    Lee CT; Chu CA; Wang YM; Wang YW; Chen YL; Ho CL; Yeh YM; Lin PC; Lin BW; Chen PC; Chen SH; Chan RH; Chang C; Chow NH
    Mol Carcinog; 2023 Jul; 62(7):951-962. PubMed ID: 37014154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 as an indicator of lymph node metastases in invasive early colorectal cancer.
    Makino M; Yamane N; Taniguchi T; Honboh T; Kurayoshi K; Kaibara N
    Anticancer Res; 2000; 20(3B):2055-9. PubMed ID: 10928151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
    Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
    Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy enhances the aggressiveness of human colorectal cancer cells and their ability to adapt to apoptotic stimulus.
    Zheng HY; Zhang XY; Wang XF; Sun BC
    Cancer Biol Med; 2012 Jun; 9(2):105-10. PubMed ID: 23691463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association Between HSP90/topoisomerase I Immunophenotype and the Clinical Features of Colorectal Cancers in Respect to
    Bar JK; Lis-Nawara A; Grelewski P; Noga L; Grzebieniak Z; Jeleń M
    Anticancer Res; 2017 Sep; 37(9):4953-4960. PubMed ID: 28870917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological and genetic differences between polypoid and non-polypoid submucosal colorectal carcinoma.
    Hirata I; Wang FY; Murano M; Inoue T; Toshina K; Nishikawa T; Maemura K
    World J Gastroenterol; 2007 Apr; 13(14):2048-52. PubMed ID: 17465446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines.
    Vitiello PP; Cardone C; Martini G; Ciardiello D; Belli V; Matrone N; Barra G; Napolitano S; Della Corte C; Turano M; Furia M; Troiani T; Morgillo F; De Vita F; Ciardiello F; Martinelli E
    J Exp Clin Cancer Res; 2019 Jan; 38(1):41. PubMed ID: 30691487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.
    Li W; Zhi W; Zou S; Qiu T; Ling Y; Shan L; Shi S; Ying J
    PLoS One; 2015; 10(6):e0128202. PubMed ID: 26042813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.